Navigation Links
Fred Hutch evolutionary geneticist Harmit Malik selected as an HHMI investigator
Date:5/9/2013

SEATTLE Harmit Singh Malik, Ph.D., an evolutionary geneticist at Fred Hutchinson Cancer Research Center who studies genetic conflict the competition between genes and proteins with opposing functions that drives evolutionary change has been selected to become a Howard Hughes Medical Institute investigator. He is among 27 of the nation's top biomedical scientists to receive the honor this year out of a pool of more than 1,100 applicants.

"HHMI has a very simple mission," said HHMI President Robert Tjian. "We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes." HHMI investigators have the freedom to explore and, if necessary, to change direction in their research. They also have support to follow their ideas through to fruition, even if that process takes many years.

Malik's initial five-year appointment as an HHMI investigator, which will begin in September, comes with a salary, benefits and a research budget. The Institute also will cover additional expenses, including research space and the purchase of critical equipment. The appointment may be renewed for additional five-year terms, each contingent upon a successful scientific review.

Malik, a member of the Fred Hutch Basic Sciences Division, has been an HHMI Early Career Scientist since 2009. His research harnesses the tools of biochemistry and genomics to chronicle the endless "genetic arms race" not just between organisms and pathogens but also within an individual species' genome.

"Harmit thinks creatively and fearlessly about his research. It is not that Harmit thinks outside of the box. It's that he does not even recognize the existence of boxes," said Mark Groudine, M.D., Ph.D., senior vice president and deputy director of Fred Hutch and a member of the Center's Basic Sciences Division.

Studying model organisms such as fruit flies and yeast, Malik sees conflicts raging within the nuclei of cells as genes jockey for evolutionary dominance. Such clashes can have a long-term impact on organisms, as they can alter the function of essential genes.

Delving deeper into genes that help fend off viral conflicts, Malik and colleagues have shown that adaptations in those genes offer a record of indirect "paleovirology," in which scientists try to identify ancient viruses by virtue of the imprints they leave on the evolution of host genes.

The structure of our genome reflects a "negotiated truce," Malik said, and the best way to understand that truce is to reconstruct the events that produced it. This approach has profound implications for medicine and science because it uncovers new antiviral strategies, mechanisms of immunity and clues about autoimmune diseases such as lupus.

Malik's lab also investigates evolutionary competition between components that are involved in the essential process that ensures chromosomes divide and segregate equally during cell division. He has pioneered the idea that chromosomal competition for evolutionary dominance can drive the unexpectedly rapid evolution of these essential components. These findings have direct implications for how chromosomal imbalances can occur in cancer and for how two recently diverged species can become reproductively isolated from each other.

Malik's many awards include the Vilcek Prize for Creative Promise in Biomedical Science for his work on the coevolution of humans and diseases, a Sloan Research Fellowship, a Kimmel Scholar Award, a Searle Scholar Award and a Burroughs Wellcome New Investigator Award in Infectious Diseases. He is also the recipient of the Presidential Early Career Award for Scientists and Engineers, the nation's highest honor for scientists at the beginning of their independent research careers.

Malik earned his undergraduate degree in chemical engineering from the Indian Institute of Technology in Mumbai before obtaining a Ph.D. from the University of Rochester in 1999. He then came to Fred Hutch as a postdoctoral fellow in the Basic Sciences laboratory of Steven Henikoff, Ph.D., who is also an HHMI investigator. Malik joined the Fred Hutch faculty in 2003.

The roster of HHMI-funded researchers from Fred Hutch includes two Early Career Scientists, including Malik; two current investigators, including Nobel laureate Linda B. Buck, Ph.D.; and seven investigator alumni.


'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related biology news :

1. Space research institute honors Sen. Hutchison with Pioneer Award
2. Fred Hutchinson Cancer Research Center partners with GlaxoSmithKline to develop muscular dystrophy therapeutics
3. Leading evolutionary scientist to discuss how genome of bacteria has evolved
4. An evolutionary surprise
5. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
6. Scientists trace evolutionary history of what mammals eat
7. Battle of the sexes offers evolutionary insights
8. Revolutionary project will obtain entire genome sequences in fight against Alzheimers
9. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
10. Tamarisk biocontrol efforts get evolutionary boost
11. Researchers dig through the gene bank to uncover the roots of the evolutionary tree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016   Avanade is helping Williams Martini ... in history, exploit biometric data in order to critically ... the competitive edge against their rivals after their impressive, ... Avanade has worked with Williams during the 2016 season ... (heart rate, breathing rate, temperature and peak acceleration) for ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
(Date:12/6/2016)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the ... €500.0 million principal amount of its 1.414% senior unsecured notes ... senior unsecured notes due 2026. The closing ... subject to the satisfaction of customary closing conditions.  The notes ... The Company intends to use the net proceeds ...
Breaking Biology News(10 mins):
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... Texas , Dec. 7, 2016  Genprex, ... of revolutionary immunogene therapy treatments, today announced that ... practice within a leading strategic communications and advisory ... communications program. The program will combine investor relations, ... objective of raising the profile of Genprex and ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, 2016 /PRNewswire/ ... immune modulatory medicines, announced today the initiation of a ... candidate, LYC-30937- E nteric C oated, in patients ... that is estimated to affect as many as 7.5 million ... with approximately 1.5 - 3 million cases being diagnosed ...
Breaking Biology Technology: